Graf Global Corp. (GRAF): Nasdaq/NYSE listing notice — Graf Global receives NYSE American delisting notice for late 10-K filing

Graf Global Corp.

Received April 16, 2026 notice of non-compliance with Section 1007 for failing to file 2025 10-K on time.
Automatic six-month cure period from original 10-K due date to file and regain compliance; delisting if not cured.
Company may request up to additional six months if needed, but no assurance of acceptance.
Securities continue trading on NYSE American during cure period, but delisting procedures may start earlier.
Company intends to file the 10-K as soon as practicable to address the deficiency.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.99

Graf Global Corp. received a nyse_american noncompliance notice notice regarding late filing (rules 1007).

Exchange: nyse american
Notice: noncompliance notice
Deficiency: late filing
Rules: 1007

Exact text from the filing

April 16, 2026, the Company received a notice (the “Notice”) from the NYSE Regulation staff of the NYSE American LLC (the “NYSE American”) stating that the Company is not in compliance with Section 1007 of the NYSE American Company Guide (the “Rule”) because it has not timely filed its Annual Report with the SEC. The Rule requires listed companies to timely file all required periodic financial reports with the SEC. The Notice has no immediate effect on the listing or trading of the Company’s securities. However, if the Company fails to timely regain compliance with the Rule, the Company’s secu

View on SEC.gov

Browse all listing & compliance notices →

Graf Global Corp. filing history →

Source: SEC EDGAR

accession 0001104659-26-046884

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.